Trade Names: | |
Synonyms: | |
Status: | Approved (1989) |
Entry Type: | Protein |
Molecule Category: | Salt |
UNII: | 6YUU2PV0U8 |
Parent Compound: | GOSERELIN |
InChI Key | IKDXDQDKCZPQSZ-JHYYTBFNSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C61H88N18O16 |
Molecular Weight | 1329.48 |
AlogP | None |
Hydrogen Bond Acceptor | None |
Hydrogen Bond Donor | None |
Number of Rotational Bond | None |
Polar Surface Area | None |
Molecular species | None |
Aromatic Rings | None |
Heavy Atoms | None |
Action | Mechanism of Action | Reference |
---|---|---|
AGONIST | Gonadotropin-releasing hormone receptor agonist | DailyMed |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Breast Neoplasms | 4 | D001943 | ClinicalTrials |
Breast Neoplasms | 4 | D001943 | ClinicalTrials |
Infertility | 3 | D007246 | ClinicalTrials |
Menopause | 3 | D008593 | ClinicalTrials |
Prostatic Neoplasms, Castration-Resistant | 3 | D064129 | ClinicalTrials |
Prostatic Neoplasms | 3 | D011471 | ClinicalTrials |
Prostatic Neoplasms | 3 | D011471 | ClinicalTrials |
Peritoneal Neoplasms | 2 | D010534 | ClinicalTrials |
Salivary Gland Neoplasms | 2 | D012468 | ClinicalTrials |
Fallopian Tube Neoplasms | 2 | D005185 | ClinicalTrials |
Ovarian Neoplasms | 2 | D010051 | ClinicalTrials |
Breast Neoplasms, Male | 1 | D018567 | ClinicalTrials |
Metabolic Syndrome | 1 | D024821 | ClinicalTrials |
Resources | Reference |
---|---|
ChEMBL | CHEMBL1200501 |
EPA CompTox | DTXSID9046736 |
FDA SRS | 6YUU2PV0U8 |
PubChem | 16052011 |
SureChEMBL | SCHEMBL6094 |